Silvercrest Asset Management Group LLC Castle Biosciences Inc Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q2 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 279,959 shares of CSTL stock, worth $6.44 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
279,959
Previous 198,802
40.82%
Holding current value
$6.44 Million
Previous $3.98 Million
43.62%
% of portfolio
0.04%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding CSTL
# of Institutions
169Shares Held
27.3MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$70.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$49.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$41.4 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$34.3 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$31.7 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $605M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...